FDA
-
-
-
-
-
-
-
Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership
-
-
-
-
-
-
-
Q BioMed Awarded Federal Supply Contract for Strontium89 with U.S. Department of Defense and Veterans Affairs
-
-
-
-
-
-
-
Q BioMed, Inc. CEO Discusses Recently Announced International Market Authorizations and Expansion in to South and Central America and Asia for Q BioMed’s Strontium89, its FDA Approved Drug for the N
-
-
-
-
-
-
-
Q BioMed Launches New Website Strontium89.com and Digital Marketing Campaign for Strontium89 (Strontium Chloride Sr-89 Injection, USP) Non-opioid Treatment for Metastatic Bone Pain
-
-
-
-
-
-
-
Q BioMed Announces Commercial Partnership With Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States
-
-
-
-
-
-
-
Biotechnology Accelerator, Q BioMed Inc., Selects 5W Public Relations as Agency of Record
-
-
-
-
-
-
-
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

